Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2/3 3Phase 2 2Phase 4 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pruritus 1Prostatic Neoplasms 1Pain 1Neuropathy, Painful 1Neuralgia 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Liver Neoplasms 1Colorectal Neoplasms 1Cold Hypersensitivity 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Zoledronic Acid 2pegfilgrastim 1Samarium-153 1Samarium 1Radiotherapy 1Prednisone 1Pamidronate 1Lidocaine 1Ketamine 1Genistein 1Filgrastim 1Fentanyl 1Extracorporeal Shockwave Therapy 1Docetaxel 1D-methadone 1Azacitidine 1Antibodies, Monoclonal 1Amantadine 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Pain × Lidocaine × Clear all
NCT07034950 2025-09-11

Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation

The First Affiliated Hospital of Xiamen University

Phase 1/2 Active not recruiting
79 enrolled
Gastrointestinal

Liver Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡